The New York Times – Business:
The company said its vaccine generated $3.5 billion in revenue in the first three months of this year.
This post first appeared in The New York Times – Business. Read the original article.

The New York Times – Business:
The company said its vaccine generated $3.5 billion in revenue in the first three months of this year.
This post first appeared in The New York Times – Business. Read the original article.